- •Preface
- •Contents
- •List of Abbreviations
- •Antibacterial Agents
- •A. TOPICAL ANTIBIOTICS
- •B. ORAL ANTIBIOTICS
- •C. ANTIBIOTICS FOR SUBCONJUNCTIVAL/INTRAVITREAL INJECTION
- •D. REGIMENS FOR SPECIFIC ORGANISMS
- •E. REGIMENS FOR SPECIFIC CLINICAL ENTITIES
- •7 Dacryocystitis
- •Antifungal Agents
- •A. AGENTS
- •B. SPECIFIC ANTI-FUNGAL REGIMENS
- •2 Molds
- •3 Dimorphic Fungi
- •Antiviral Agents
- •A. TOPICAL
- •B. SYSTEMIC
- •Anti-Parasitic Agents
- •A. PROTOZOA
- •B. HELMINTHS
- •Anti-Glaucoma Agents
- •D. HYPEROSMOLAR AGENTS
- •H. COMBINATION AGENTS
- •I. SPECIFIC REGIMENTS
- •2 Elevated Eye Pressure During Pregnancy
- •Neuro-Ophthalmology
- •A. AGENTS USED IN NEURO-OPHTHALMOLOGY
- •B. SPECIFIC REGIMENS
- •Anti-Inflammatory Agents
- •A. STEROIDAL
- •B. COMBINATION STEROID WITH ANTIBIOTIC
- •C. NONSTEROIDAL
- •D. MISCELLANEOUS
- •Mydriatics, Cycloplegics, and Reversal Agents
- •Lubricants and Viscoelastics
- •A. ARTIFICIAL TEARS, VISCOELASTICS, AND LUBRICATING OINTMENTS
- •Low Viscosity
- •High Viscosity
- •Unknown Viscosity
- •Insert
- •Gels & Ointments
- •Ointments
- •Gels
- •Viscoelastics
- •B. IRRIGATING SOLUTIONS
- •Miscellaneous
- •A. AGENTS FOR RELIEF OF SEASONAL ALLERGIC CONJUNCTIVITIS/OCULAR DISCOMFORT
- •B. OCULAR DECONGESTANTS
- •C. TOPICAL HYPEROSMOLAR AGENTS
- •D. VITAMINS
- •E. ANESTHETIC AGENTS
- •F. HOMEOPATHIC DRUGS
- •G. CAPSULE STAINING ADJUNCTS
- •H. MISCELLANEOUS
- •I. DRUGS FOR HYPHEMA
- •Anti-Angiogenesis Agents
- •Contact Lens Solutions
- •Contact Lens Solution Hypersensitivity
- •Soft Contact Lens Solutions
- •I. LISTING OF SOFT LENS PRODUCTS BY CATEGORY
- •A. Daily Cleaners
- •B. Enzymatic Cleaners
- •C. Daily Protein Removers
- •D. Rewetting/Lubricating Drops
- •E. Oxidation Solutions/Systems
- •F. Saline Solutions
- •G. Combination Solutions
- •II. SOFT LENS PRODUCTS LISTED BY SYSTEM AND MANUFACTURER: NOT ALL PRODUCTS ARE LISTED IN THIS SECTION BECAUSE NOT ALL PRODUCTS BELONG TO A PARTICULAR SYSTEM
- •Rigid Lens Solutions
- •I. LISTING OF RIGID LENS RODUCTS BY CATEGORY
- •A. Daily Cleaners
- •C. Daily Protein Remover
- •D. Oxidation Systems
- •E. Storage and Disinfection
- •F. Wetting/Rewetting
- •G. Combination Solutions
- •APPENDIX 1: TOPICAL ANTIBACTERIAL SPECTRUM
- •APPENDIX 2: A PREPARING FORTIFIED TOPICAL ANTIBIOTICS AND PREPARING ORAL ACETAZOLAMIDE SOLUTION
- •Fortified Bacitracin
- •Fortified Cefazolin
- •Fortified Vancomycin
- •APPENDIX 3: ANTI-FUNGAL ACTIVITY SPECTRUM
- •APPENDIX 4: RENAL DOSING FOR SELECTED DRUGS
- •Cidofovir Dosing in Renal Failure*
- •Famciclovir Dosing in Renal Failure*
- •Foscarnet Dosing in Renal Failure*
- •Intravenous Ganciclovir Dosing in Renal Failure*
- •Oral Ganciclovir Dosing in Renal Failure*
- •Valacyclovir Dosing in Renal Failure*
- •APPENDIX 5: GLAUCOMA MEDICATION PRESERVATIVES
- •APPENDIX 6: TITRATING TOPICAL DROPS FOR CHILDREN
- •Product Index
- •Subject Index
Subject Index
A
Acanthamoeba, 46 Actinomyces israelii, 17 Acute retinal necrosis, 41 Adie’s pupil, 66
Alpha agonists, 54 Aminoglycoside, 2, 4, 7 Anesthetic agents, 94–96 Antibacterial spectrum, 117–118 Artifical tears, 82–87 Aspergillosis, 18, 35 Aspergillus, 18, 35
B
Bacillus cereus, 30
Band keratopathy, 98
Beta blockers, 54–55
Blastomyces dermatitidis, 36
Blastomycosis, 36
Blebitis, 26–27
Blepharitis, 14–15
Blepharospasm, 66
Borrelia burgdorferi, 12–13
C
Canaliculitis, 17–18
Candida, 29–30, 34 Candidiasis, 34
Carbonic anhydrase inhibitors, 56
Chlamydia trachomatis, 2, 10, 17 Chlamydia Urethritis, 5
Coccidioides immitis, 36 Coccidioidomycosis, 36 Conjunctivitis
allergic, 90 bacterial, 17 gonococcal, 9–10
inclusion (Chlamydial), 10–11 neonatal, 17
viral, 17 Crabs, 16
Cryptococcus neoformans, 35 Cycloplegics, 78–79 Cysticercosis, 51
Cystinosis, 98
Cytomegalovirus (CMV), 41–43, 122–123
D
Dacryoadenitis bacterial, 20
Dacryocystitis, 18 Decongestants
ocular, 91–92
Dry eye syndrome, 85
E
Encephalitozoon hellem, 47 Endophthalmitis
endogenous, 30, 34 postoperative, 29 traumatic, 29–30, 34
F
Filamentary keratitis, 98 Filariasis, 50 Fluoroquinolone, 2–3
Fortified topical antibiotics, 119 Fungal Keratitis, 34–37 Fusarium, 34, 36
G
Giant cell arteritis, 66–67, 72 Glaucoma
acute angle closure, 64 infantile, 56, 62–63
H
Haemophilus influenzae, 2, 17, 26 Helminths, 50–52
Hemifacial spasm, 66 Herpes simplex virus (HSV),
40–43, 122
Histoplasma capsulatum, 37 Histoplasmosis, 37
HIV, 8–10, 41–42 Homeopathic drugs, 96 Hordeolum, 16, 98 Horner’s syndrome, 66 Hyperosmolar agents
systemic, 57 topical, 92 Hyphema, 78, 99
Subject Index 138
I
Intrinsic sympathomimetic activity, 55 Irrigating solutions, 88
L
Leishmaniasis, 47
Lice, 16
Ligneous conjunctivitis, 76
Loa loa, 50
Lyme Disease, 12–13
M
Microsporidia, 47
Miotics, 58–59
Molds, 35–36
Moraxella catarrhalis, 17
Mucomycosis, 36
Myasthenia gravis, 54, 66
Mydriatics, 78–79
N
Neisseria gonorrhea, 4, 9, 17 Neisseria meningitidis, 2 Neuro-ophthalmology, 66–68 Neurosyphilis, 9 Nonsteroidal agents, 75
Nosema corneum, 47
O
Onchocerca volvulus, 50
Onchocerciasis, 50
Optic neuritis, 66–67, 72
Orbital cellulitis, 23–24
P
Pediculosis, 16
Phthirus pubis, 16 Pneumocystis carinii, 47 Preseptal cellulitis, 16, 21–22
Propionibacterium acnes, 29 Prostaglandins, 60
Proteus, 27 Protozoa, 46–49
Pseudomonas, 27 Pseudomonas aeruginosa, 2–4
R
Reversal agents, 78–79
River blindness, 50
Rosacea, 3, 6, 14–15
Ruptured globe, 24
S
Seasonal allergic conjunctivitis, 90
Serratia marcescens, 27 Sporothrix schenckii, 27 Sporotrichosis, 37
Staph. aureus, 17, 27, 30 Staph. epidermidis, 27, 30 Steroidal agents, 70–72
Streptococcus, 17, 26–27, 30 group B, 17
Strep. viridans, 17 Stye, 16
Superior limbic keratitis, 98 Sympathomimetic, 61 Syphilis, 8–9
T
Taenia solium, 51 Tapeworm, 51 Toxocariasis, 52
Toxoplasma gondii, 48–49 Toxoplasmosis, 48–49 Trachoma, 10–11
Traumatic optic neuropathy, 66, 68, 72
Treponema pallidum, 8–9
V
Varicella zoster virus, 41, 43 Visceral Larva Migrans, 52 Viscoelastics, 82–88 Vitamins, 93
Y
Yeast, 34–35
Z
Zygomycosis, 36
